Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Condition:   Ebola Virus Disease Intervention:   Biological: Ad26.ZEBOV, MVA-BN-Filo vaccine Sponsors:   London School of Hygiene and Tropical Medicine;   Epicentre;   Ministère de la Santé de la RDC;   Médecins Sans Frontières, France;   Coalition for Epidemic Preparedness Innovations;   Janssen Vaccines & Prevention B.V.;   Public Health England Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials